A novel heterologous prime boost vaccine system drives tumor specific and potent CD8 T cell responses for cancer immunotherapy

被引：0
|
作者：
Blair, Wade [1 ]
Grotenbreg, Gijsbert [1 ]
Scallan, Ciaran [1 ]
Rappaport, Amy [1 ]
Greer, Renee [1 ]
Gitlin, Leonid [1 ]
Lam, Kieu [2 ]
Heyes, James [2 ]
Van Abbema, Anne [1 ]
Hanson, Hadley [1 ]
Schreiner, Petra [2 ]
Jooss, Karin [1 ]
机构：
[1] Gritstone Oncol, Emeryville, CA USA
[2] Arbutus Biopharma, Burnby, BC, Canada
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-724
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
724
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Potent HIV-1-specific CD8 T Cell Responses Induced in Mice After Immunization With a Heterologous DNA-TMEP Prime/MVA-B Vaccine Boost Regimen
    Perdiguero, Beatriz
    Raman, Suresh C.
    Sanchez-Corzo, Cristina
    Sorzano, Carlos Oscar S.
    Ramon Valverde, Jose
    Esteban, Mariano
    Elena Gomez, Carmen
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 326 - 326
  • [2] Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses
    Ring, Sandra S.
    Krolik, Michal
    Hartmann, Fabienne
    Schmidt, Erika
    Ali, Omar Hasan
    Ludewig, Burkhard
    Kochanek, Stefan
    Flatz, Lukas
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 19 : 179 - 187
  • [3] Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack
    Bonilla, Weldy, V
    Kirchhammer, Nicole
    Marx, Anna-Friederike
    Kallert, Sandra M.
    Krzyzaniak, Magdalena A.
    Lu, Min
    Darbre, Stephanie
    Schmidt, Sarah
    Raguz, Josipa
    Berka, Ursula
    Vincenti, Ilena
    Pauzuolis, Mindaugas
    Kerber, Romy
    Hoepner, Sabine
    Guenther, Stephan
    Magnus, Carsten
    Merkler, Doron
    Orlinger, Klaus K.
    Zippelius, Alfred
    Pinschewer, Daniel D.
    CELL REPORTS MEDICINE, 2021, 2 (03)
  • [4] Heterologous prime-boost immunizations with different Salmonella serovars for enhanced antigen-specific CD8 T-cell induction
    Domenech, Victoria E. Sevil
    Panthel, Klaus
    Winter, Sebastian E.
    Ruessmann, Holger
    VACCINE, 2008, 26 (15) : 1879 - 1886
  • [5] CD8 and CD4 T cell collaboration in tumor specific CTL responses
    Goldberg, JE
    Mescher, MF
    FASEB JOURNAL, 2001, 15 (04): : A658 - A658
  • [6] TCR signal strength drives tumor-specific CD8 T cell differentiation
    Carson, Sandra
    Schietinger, Andrea
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [7] Splenic dendritic cell subsets prime and boost CD8 T cells and are involved in the generation of effector CD8 T cells
    Behboudi, S
    Moore, A
    Hill, AVS
    CELLULAR IMMUNOLOGY, 2004, 228 (01) : 15 - 19
  • [8] Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy
    Leen, Ann M.
    Christin, Anne
    Khalil, Mariam
    Weiss, Heidi
    Gee, Adrian P.
    Brenner, Malcolm K.
    Heslop, Helen E.
    Rooney, Cliona M.
    Bollard, Catherine M.
    JOURNAL OF VIROLOGY, 2008, 82 (01) : 546 - 554
  • [9] Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes
    Gilbert, SC
    Schneider, J
    Hannan, CM
    Hu, JT
    Plebanski, M
    Sinden, R
    Hill, AVS
    VACCINE, 2002, 20 (7-8) : 1039 - 1045
  • [10] 4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine
    Harrison, Jodie M.
    Bertram, Edward M.
    Boyle, David B.
    Coupar, Barbara E. H.
    Ranasinghe, Charani
    Ramshaw, Ian A.
    VACCINE, 2006, 24 (47-48) : 6867 - 6874
12345